Orbimed Advisors - AADI BIOSCIENCE INC ownership

AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 33 filers reported holding AADI BIOSCIENCE INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of AADI BIOSCIENCE INC
ValueSharesWeighting
Q4 2021$3,082,000
-69.7%
127,600
-63.1%
0.04%
-64.3%
Q3 2021$10,170,000346,2620.11%
Other shareholders
AADI BIOSCIENCE INC shareholders Q3 2021
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 26,666$342,12526.12%
Alerce Investment Management, L.P. 1,630,830$20,923,54924.07%
ACUTA CAPITAL PARTNERS, LLC 1,849,402$19,622,22812.08%
Ally Bridge Group (NY) LLC 632,997$8,121,3527.90%
Decheng Capital Management III (Cayman), LLC 526,329$6,752,8012.53%
Opaleye Management Inc. 252,046$3,233,7501.12%
Vivo Capital, LLC 509,572$6,5380.75%
Lynx1 Capital Management LP 64,739$830,6010.72%
Avoro Capital Advisors LLC 2,849,402$36,557,8280.55%
Ghost Tree Capital, LLC 90,000$1,155,0000.49%
View complete list of AADI BIOSCIENCE INC shareholders